Actio Biosciences
About:
Actio Biosciences is a research center that develops drugs for rare diseases.
Website: https://www.actiobiosciences.com
Top Investors: Canaan Partners, EcoR1 Capital, Deerfield Management, Euclidean Capital, Droia Ventures
Description:
Actio Biosciences involves in the development of precision medicines for homogenous rare patient populations. They develop a pipeline of new medicines with the goal to enhance the probability of clinical success and deliver medicines for all patients.
Total Funding Amount:
$55M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Diego, California, United States
Founded Date:
2021-01-01
Founders:
David Goldstein
Number of Employees:
11-50
Last Funding Date:
2023-09-12
IPO Status:
Private
Industries:
© 2025 bioDAO.ai